Everolimus plus trastuzumab and vinorelbine for trastuzumabresistant, taxane-pretreated, HER2+advanced breast cancer: Overall survival results from BOLERO-3

Yazar
Jappe, A.
Ozguroglu, M.
Zhang, Y.
Pacaud, L. B.
Taran, T.
Isaacs, C.
O'Regan, R.
Xu, B.
Masuda, N.
Arena, F.
Yap, Y-S
Papal, Z.
Lang, I.
Armstrong, A.
Lerzo, G.
White, M.
Shen, K.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/22911
https://doi.org/10.1158/1538-7445.sabcs15-p4-13-12
Koleksiyonlar